A significant outbreak of respiratory human adenovirus infections among children aged 3-6 years in Hokkaido, Japan, in 2023
- PMID: 38965887
- DOI: 10.1002/jmv.29780
A significant outbreak of respiratory human adenovirus infections among children aged 3-6 years in Hokkaido, Japan, in 2023
Abstract
Human adenovirus (HAdV) infections present diverse clinical manifestations upon infecting individuals, with respiratory infections predominating in children. We surveyed pediatric hospitalizations due to respiratory HAdV infections across 18 hospitals in Hokkaido Prefecture, Japan, from July 2019 to March 2024, recording 473 admissions. While hospitalizations remained below five cases per week from July 2019 to September 2023, a notable surge occurred in late October 2023, with weekly admissions peaking at 15-20 cases from November to December. There were dramatic shifts in the age distribution of hospitalized patients: during 2019-2021, 1-year-old infants and children aged 3-6 years represented 51.4%-54.8% and 4.1%-13.3%, respectively; however, in 2023-2024, while 1-year-old infants represented 19.0%-20.1%, the proportion of children aged 3-6 years increased to 46.2%-50.0%. Understanding the emergence of significant outbreaks of respiratory HAdV infections and the substantial changes in the age distribution of hospitalized cases necessitates further investigation into the circulating types of HAdV in Hokkaido Prefecture and changes in children's neutralizing antibody titers against HAdV.
Keywords: Japan; child; epidemiology; human adenovirus; neutralizing antibody.
© 2024 Wiley Periodicals LLC.
References
REFERENCES
-
- Shieh WJ. Human adenovirus infections in pediatric population: an update on clinico‐pathologic correlation. Biomedical J. 2022;45:38‐49. doi:10.1016/j.bj.2021.08.009
-
- Gutierrez Sanchez LH, Shiau H, Baker JM, et al. A case series of children with acute hepatitis and human adenovirus infection. N Engl J Med. 2022;387:620‐630. doi:10.1056/NEJMoa2206294
-
- Lynch 3rd, JP, Kajon AE. Adenovirus: epidemiology, global spread of novel serotypes, and advances in treatment and prevention. Semin Respir Crit Care Med. 2016;37(586):586‐602. doi:10.1055/s-0036-1584923
-
- Lu X, Joshi A, Flomenberg P. Adenoviruses. In: Kaslow RA, Stanberry LR, Powers AM, eds, Viral Infections of Humans. Springer. doi:10.1007/978-1-4939-9544-8_6-1
-
- Mennechet FJD, Paris O, Ouoba AR, et al. A review of 65 years of human adenovirus seroprevalence. Expert Rev Vaccines. 2019;18:597‐613. doi:10.1080/14760584.2019.1588113
MeSH terms
LinkOut - more resources
Full Text Sources